Montelucaste Bluefish (Montelukast)

Montelukast blocks the cysteinyl leukotriene receptor CysLT1 on airway smooth muscle and inflammatory cells. This inhibition prevents leukotriene‑mediated bronchoconstriction, mucus production, and inflammation, helping to keep the airways open and reduce allergic symptoms.

The appropriate dose of Montelucaste Bluefish is determined by the prescribing clinician based on the patient’s age, weight, condition being treated, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for montelukast in pregnancy are limited, and the drug is classified as pregnancy category unknown. It should only be used if the potential benefit justifies any potential risk to the fetus. While limited data exist for lactation, a healthcare professional should evaluate the risk‑benefit ratio before use while breastfeeding.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids and long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑exacerbated respiratory disease or those who need additional control of nighttime symptoms, but it does not replace rescue bronchodilators for acute attacks.

Store Montelucaste Bluefish at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture and direct sunlight, and keep out of reach of children.

Montelucaste Bluefish is taken orally, usually once daily in the evening, with or without food, as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water; it should not be crushed, chewed, or split unless specifically advised.

Serious adverse events, although rare, include neuropsychiatric reactions such as agitation, anxiety, depression, or suicidal thoughts, as well as severe allergic responses like anaphylaxis and Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience mood changes, rash, swelling, or breathing difficulties.

Montelucaste Bluefish is contraindicated in individuals with known hypersensitivity to montelukast or any of the tablet’s excipients. Caution is advised for patients with severe liver impairment, and it should be avoided in pregnant or breastfeeding women unless the prescriber determines that the benefits outweigh the risks.